Zn-Phenanthroline-Dicarboxylate Complex: A Dual Inhibitor of COX-2 and 5-LOX Enzymes

被引:0
|
作者
Rambabu, Darsi [1 ]
Sharma, Shilpa [2 ]
Mayank [3 ]
Singh, Narinder [2 ]
Shagun [4 ]
Pooja [5 ]
机构
[1] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain La Neuve, Belgium
[2] Indian Inst Technol Ropar, Dept Chem, Rupnagar 140001, India
[3] Univ Coll Pharm, Guru Kashi Univ, Talwandi Sabo 151302, India
[4] Indian Inst Technol Mandi, Sch Chem Sci, Mandi 175001, India
[5] DAV Coll, Post Grad Dept Chem, Jalandhor 144008, Punjab, India
来源
CHEMISTRYSELECT | 2024年 / 9卷 / 23期
关键词
COX-2; 5-LOX; Inhibitors; Metal Complexes; Crystal Structures; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CYCLOOXYGENASE-2; COX-2; 5-LIPOXYGENASE;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A series of new phenanthroline-based metal complexes, coordination polymers are synthesized using 1,10-phenanthroline 2,9-dicarboxylate (PDA) and different metal salts including tin (R-1 to R-3), manganese (R-4), ruthenium (R-5), and zinc (R-6) respectively. The inhibitory activities of synthesized coordination compounds are evaluated towards COX-2 (cyclooxygenase-2) and 5-LOX (5-lipoxygenase) enzymes. Among all the metal-organic coordination complexes, Zn-PDA (R-6) shows most prominent inhibitory activity than other systems with the IC50 value of 0.0524 mu g/mL and 0.834 mu g/mL for both COX-2 and 5-LOX enzymes, respectively. The synthesized systems were also evaluated for their activity against COX-1 and standard COX-2 inhibitors viz. Rofecoxib and Aspirin. The rationale for R-6 being the most potent metal complex for dual COX-2 and 5-LOX inhibition is demonstrated using docking studies. A series of Metal-phenanthroline-carboxylate- coordination compounds (R1 to R6) were designed and synthesized. Among all the metal complexes tested for inhibitory activities for COX-2 and 5-LOX enzymes, the activities of R-1 and R-6 were found to be most potent. image
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Design of Dual COX-2 and 5-LOX Inhibitors with Iron-Chelating Properties Using Structure-Based and Ligand-Based Methods
    Boskovic, Jelena
    Ruzic, Dusan
    Cudina, Olivera
    Nikolic, Katarina
    Dobricic, Vladimir
    LETTERS IN DRUG DESIGN & DISCOVERY, 2022, 19 (04) : 279 - 292
  • [42] A COX/5-LOX Inhibitor Licofelone Revealed Anticonvulsant Properties Through iNOS Diminution in Mice
    Payandemehr, Borna
    Khoshneviszadeh, Mahsima
    Varastehmoradi, Bardia
    Gholizadeh, Ramtin
    Bahremand, Taraneh
    Attar, Hossein
    Bahremand, Arash
    Dehpour, Ahmad Reza
    NEUROCHEMICAL RESEARCH, 2015, 40 (09) : 1819 - 1828
  • [43] Discovery of COX-2 and 5-LOX dual targeted inhibitors from Nauclea officinalis by employing a combination of affinity ultrafiltration and HPLC-MS/MS
    Wang, Guanghou
    Tang, Xueqian
    Qin, Feixu
    Wang, Hongjin
    Zhang, Hao
    Li, Hanyue
    Wei, Lan
    Sun, Lixin
    MICROCHEMICAL JOURNAL, 2024, 207
  • [44] QSAR and Docking Studies on Propenone Derivatives as Dual COX and 5-LOX Inhibitors
    Sivakumar, Ponnurengam M.
    Babu, Sethu K. Geetha
    Sharma, Vaibhav
    Doble, Mukesh
    LETTERS IN ORGANIC CHEMISTRY, 2008, 5 (07) : 544 - U23
  • [45] Systematic insight into the dual COX-2/5-LOX inhibitory mechanism of Duhuo Jisheng decoction for treatment of osteoarthritis based on in silico and bioassay
    Zhang, Min
    Li, Yaling
    Liu, Hao
    Hao, Guoxiong
    Zhang, Huijuan
    Li, Mi
    Li, Chenghao
    Qiu, Lu
    Hou, Yehu
    Li, Jintian
    Xue, Weiwei
    Liu, Yongqi
    Jin, Xiaojie
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 340
  • [46] Design, synthesis, and evaluation of benzhydrylpiperazine-based novel dual COX-2/5-LOX inhibitors with anti-inflammatory and anti-cancer activity
    Saraf, Poorvi
    Bhardwaj, Bhagwati
    Verma, Akash
    Siddiqui, Mohammad Aquib
    Verma, Himanshu
    Kumar, Pradeep
    Srivastava, Samridhi
    Krishnamurthy, Sairam
    Srikrishna, Saripella
    Shrivastava, Sushant Kumar
    RSC MEDICINAL CHEMISTRY, 2025, 16 (01): : 200 - 220
  • [47] Synthesis of diarylidenecyclohexanone derivatives as potential anti-inflammatory leads against COX-2/mPGES1 and 5-LOX
    Kar, Swayamsiddha
    Ramamoorthy, Gayathri
    Sinha, Shweta
    Ramanan, Meera
    Pola, Jeevan Kumar
    Golakoti, Nageswara Rao
    Nanubolu, Jagadeesh Babu
    Sahoo, Suraj Kumar
    Dandamudi, Rajesh Babu
    Doble, Mukesh
    NEW JOURNAL OF CHEMISTRY, 2019, 43 (23) : 9012 - 9020
  • [48] Protective effects of nimesulide (COX inhibitor), AKBA (5-LOX inhibitor), and their combination in aging-associated abnormalities in mice
    Bishnoi, M
    Patil, CS
    Kumar, A
    Kulkarni, SK
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2005, 27 (07): : 465 - 470
  • [49] Unveiling a novel pyrazolopyrimidine scaffold as a dual COX-2/5-LOX inhibitor with immunomodulatory potential: Design, synthesis, target prediction, anti-inflammatory activity, and ADME-T with docking simulation
    Ragab, Ahmed
    Ayman, Radwa
    Salem, Mohamed A.
    Ammar, Yousry A.
    Abusaif, Moustafa S.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 290
  • [50] A novel class of tyrosine derivatives as dual 5-LOX and COX-2/mPGES1 inhibitors with PGE2 mediated anticancer properties
    Puratchikody, Ayarivan
    Umamaheswari, Appavoo
    Irfan, Navabshan
    Sinha, Shweta
    Manju, S. L.
    Ramanan, Meera
    Ramamoorthy, Gayathri
    Doble, Mukesh
    NEW JOURNAL OF CHEMISTRY, 2019, 43 (02) : 834 - 846